<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18279">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01862510</url>
  </required_header>
  <id_info>
    <org_study_id>ZUBM12133</org_study_id>
    <nct_id>NCT01862510</nct_id>
  </id_info>
  <brief_title>Detection of Celiac Disease in Patients With Hypothyroidism</brief_title>
  <official_title>Detection of Celiac Disease in Patients With Hypothyroidism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Vermont</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine
      to maintain a euthyroid state are at increased risk of having celiac disease. It also
      attempts to determine if there is a threshold level of levothyroxine needed to maintain a
      euthyroid state in patients with hypothyroidism that should prompt serologic testing for
      celiac disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>presence of celiac disease</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms associated with celiac disease</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>a short questionnaire will be filled out at the time of serologic testing. If a patient hads celiac disease the form will be filled out again at 6 months after diagnosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>medication adjustment</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients diagnosed with celiac disease who initiate a gluten free diet will be assessed to determine whether adjustment of levothyroxine dosing is necessary</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Celiac Disease</condition>
  <condition>Hypothyroidism</condition>
  <condition>Celiac Sprue</condition>
  <condition>Malabsorption</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with hypothyroidism who take thyroid replacement therapy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with the diagnosis of hypothyroidism that require thyroid replacement
             therapy.

        Exclusion Criteria:

          -  Surgical resection of thyroid tissue, neck irradiation, radioactive iodine therapy,
             prior medical treatment with lithium, methimazole, propylthiouracil, ethionamide,
             amiodarone, or sunitinib, prior serologic testing for celiac disease.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Zubarik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vermont</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>RIchard Zubarik, MD</last_name>
    <phone>802-847-8865</phone>
    <email>Richard.Zubarik@vtmednet.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fletcher Allen Health Care</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Zubarik, MD</last_name>
      <phone>802-847-8865</phone>
      <email>richard.zubarik@vtmednet.org</email>
    </contact>
    <investigator>
      <last_name>Richard Zubarik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Collins D, Wilcox R, Nathan M, Zubarik R. Celiac disease and hypothyroidism. Am J Med. 2012 Mar;125(3):278-82. doi: 10.1016/j.amjmed.2011.09.003.</citation>
    <PMID>22340926</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 21, 2013</lastchanged_date>
  <firstreceived_date>May 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vermont</investigator_affiliation>
    <investigator_full_name>Richard Zubarik</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Celiac Disease</keyword>
  <keyword>Hypothyroidism</keyword>
  <keyword>Celiac Sprue</keyword>
  <keyword>Malabsorption</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Celiac Disease</mesh_term>
    <mesh_term>Hypothyroidism</mesh_term>
    <mesh_term>Malabsorption Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
